Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
product_variation
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
product_variation

Uncategorized

  • 9
    Jul

    Milestone for BioNTech

    325 Million USD for further development of its cancer immunotherapy. Learn more at:

    MORE →

  • 22
    Apr

    Eli Lilly and Avidity Biosciences announce licensing & research cooperation

    on combined monoclonal antibodies and oligonucleotide-based therapies for potential new medicines in immunology and other select indications. Read more here:

    MORE →